Jain Global’s Medline Inc MDLN Stock Holding History

Jain Global’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.31M	Buy	+74,400	New	+$3.28M	0.01%	575

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $3.85B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Jain Global's MDLN Position: Q1 2026 in Review

Jain Global reduced its Medline Inc (MDLN) stake by 41% in Q1 2026, selling an estimated $6.03M and leaving 198,469 shares worth $8.83M. The position accounts for 0.04% of the portfolio, ranked #362.

Jain Global first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. The position peaked at $14.1M in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Jain Global held 198,469 shares of Medline Inc worth $8.83M as of Q1 2026.
Jain Global sold 136,528 Medline Inc shares in Q1 2026, an estimated $6.03M.
Medline Inc made up 0.04% of Jain Global's portfolio in Q1 2026, its #362 holding.
Jain Global first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
Jain Global's Medline Inc position peaked at $14.1M in Q4 2025.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.